시장보고서
상품코드
1272772

세계의 치주질환 치료 시장(2023-2030년)

Global Periodontal Therapeutics Market - 2023-2030

발행일: | 리서치사: DataM Intelligence | 페이지 정보: 영문 195 Pages | 배송안내 : 2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

시장 개요

세계 치주질환 치료 시장은 2022년 734억 8,800만 달러에 달할 것으로 예상되며, 2030년에는 최대 614억 5,930만 달러에 달할 것으로 예상됩니다. 치주질환 치료 시장은 예측 기간(2023-2030년) 동안 9.2%의 CAGR을 보일 것으로 예상됩니다. 항생제 사용에 이은 보조 요법이 이 시장 추세를 뒷받침할 것으로 보입니다.

비수술적 치주병 치료법에는 항균 제품 사용과 구강 내 깊은 청소가 포함되며, 이는 치주병의 초기 단계의 회복에 충분한 것으로 입증되었습니다. 치주 조직의 염증과 치태를 조절하기 위해 국소 및 경구용 항생제를 포함한 항생제를 처방합니다. 경구용 항생제는 미생물 감염으로 인해 잇몸과 치아 사이에 생긴 틈새(일반적으로 치주낭이라고 함)에 놓습니다.

치주질환은 경증부터 중증까지 다양하며, 방치하면 치아를 잃을 수도 있습니다. 세계 치주질환 치료 시장의 주요 성장 요인은 구강 위생의 중요성에 대한 인식 증가, 인구 고령화, 신제품 및 신기술 개발입니다.

시장 역학

더 나은 구강 위생에 대한 수요 증가는 예측 기간 동안 치주질환 치료의 세계 시장 성장을 가속할 것입니다

구강 위생은 건강을 유지하는 데 있어 가장 중요한 요소 중 하나가 되었습니다. 따라서 구강 위생에 대한 인식이 높아지면서 특히 선진국에서 치주질환 치료 시장을 주도하고 있습니다. 세계보건기구(WHO)는 5억 3,000만 명 이상의 어린이들이 우식증을 앓고 있다고 밝혔습니다.

항생제의 임상적 비효율성이 치주질환 치료 시장 성장을 저해

치주질환 치료에서 항생제의 부분적인 비효율성은 치주질환 치료 시장의 성장을 제한하는 중요한 요인으로 작용하고 있습니다. 치주질환 치료에서 항생제 사용은 특히 심한 치주염의 후기 단계에서 세균 감염 치료 및 포켓 치유에 대한 낮은 효율성으로 인해 제한적입니다.

항생제 치료는 주로 구강 외과 수술이나 치아 세척과 함께 사용됩니다. 또한, 질병 치료에 항생제를 과도하게 사용하거나 오용하면 항균제 내성을 유발할 수 있습니다. 이러한 요인들은 예측 기간 동안 치주질환 치료 시장의 성장을 저해할 것으로 예상됩니다.

코로나19의 영향 분석

세계 치주질환 치료 시장은 코로나19 사태로 인해 침체되어 있으며, 2020년 상반기에는 치주질환 치료에 사용되는 항생제 매출 성장률이 소폭 감소했습니다. 이는 치과 진료를 위한 병원 방문이 감소하고 세계 치과 의사들의 처방이 감소했기 때문인 것으로 보입니다.

러시아-우크라이나 분쟁 분석

세계 치주치료 시장은 러시아와 우크라이나의 지속적인 분쟁으로 인해 간접적으로 영향을 받을 수 있습니다. 분쟁으로 인해 여러 국가가 러시아에 부과한 경제 제재는 러시아 경제에 영향을 미치고 있습니다. 그 결과, 치주 치료 시장을 포함한 치과 의료 산업이 영향을 받을 수 있습니다.

러시아는 치과 의료기기의 수출입이 이루어지고 있기 때문에 전쟁의 영향으로 러시아에서 다른 국가로의 치과 의료기기공급에 차질을 빚을 수 있습니다. 또한 화이자, 바이엘, 사노피와 같은 대형 제약사들은 러시아에서의 신규 투자 및 개발을 연기하여 의약품 공급망에 혼란을 초래했습니다. 분쟁으로 인한 이러한 혼란은 세계 치주질환 치료 시장에 부정적인 영향을 미치고 있습니다.

이 보고서에 대해 자세히 알아보기 - 샘플 요청하기

목차

제1장 조사 방법과 범위

  • 조사 방법
  • 조사 목적 및 조사 범위

제2장 정의와 개요

제3장 주요 요약

  • 치료법별 개요
  • 질환 유형별 개요
  • 판매채널별
  • 지역별 개요

제4장 시장 역학

  • 영향요인
    • 촉진요인
      • 보다 좋은 구강 위생에 대한 수요 증가가 예측 기간중 치주질환 치료 세계 시장 성장을 가속
    • 성장 억제요인
      • 항생제의 임상적 비효율성이 치주질환 치료 시장 성장을 저해
    • 기회
    • 영향 분석

제5장 산업 분석

  • Porter의 Five Forces 분석
  • 공급망 분석
  • 가격 분석
  • 법규제 분석

제6장 COVID-19 분석

  • COVID-19 분석
    • COVID-19 등장 이전의 시나리오
    • 현재의 시나리오
    • COVID-19 이후 또는 향후의 시나리오
  • COVID-19 기간의 가격 및 역학
  • 수급 스펙트럼
  • 팬데믹 기간의 시장에 관련된 정부 이니셔티브
  • 제조업체의 전략적인 이니셔티브
  • 요약

제7장 치료법별

  • 전신성 항생제
  • 국소 항생제

제8장 질환 유형별

  • 치은염
  • 만성 치주염
  • 진행성 치주염
  • 괴사성 치주질환
  • 기타

제9장 유통 채널별

  • 소매 약국 및 드럭스토어
  • 병원 약국
  • 덴탈 클리닉
  • E-Commerce

제10장 지역별

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 기타 유럽
  • 남미
    • 브라질
    • 아르헨티나
    • 기타 남미
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카

제11장 경쟁 구도

  • 경쟁 시나리오
  • 시장 현황/점유율 분석
  • 인수합병(M&A) 분석

제12장 기업 개요

  • Kaken Pharmaceutical Co. Ltd.
    • 기업 개요
    • 제품 포트폴리오와 설명
    • 재무 개요
    • 주요 발전 상황
  • Bausch Health
  • Colgate-Palmolive
  • Medicom
  • Pfizer Inc.
  • 3M
  • Den-Mat Holdings, LLC
  • Dentsply Sirona
  • Xttrium Laboratories, Inc.
  • Dexcel Pharma

제13장 부록

LSH 23.05.22

Market Overview

The global periodontal therapeutics market reached US$ 734.8 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 61,459.3 million by 2030. The periodontal therapeutics market is expected to exhibit a CAGR of 9.2% during the forecast period (2023-2030). Adjuvant therapies following the use of antibiotics will support the trend in this market.

The non-surgical treatment procedures for gum disease include the use of antibacterial products and deep cleaning of the mouth which is proven to be sufficient for reversing the periodontal disease in its early stages. Antibiotics including both topical and oral are prescribed for the control of inflammation and plaque of the gum tissue. Oral antibiotics are placed in the gaps formed between gums and teeth by microbial infection, commonly called periodontal pockets.

Periodontal diseases can range from mild to severe and can cause tooth loss if left untreated. The major factors for growth of the global periodontal therapeutics market are the increasing awareness of the importance of oral health, the aging population, and the development of new products and technologies.

Market Dynamics

The increasing demand for better oral hygiene to drive global periodontal therapeutics market growth during the forecast period

Oral hygiene has become one of the most important parameters for staying healthy. Therefore, the growing awareness about oral hygiene is driving the periodontal therapeutics market, specifically in developed countries. The World Health Organization (WHO) states that over 530 million children suffer from dental caries of primary teeth.

Key players such as Procter & Gamble and Colgate-Palmolive Company have undertaken initiatives to spread awareness regarding dental hygiene, both for children and adults, creating demand for periodontal therapeutic drugs. Owing to rising awareness for better oral hygiene, the global periodontal therapeutics market will upscale at a rapid pace over the forecast period.

The clinical inefficiencies of antibiotics to hamper periodontal therapeutics market growth.

The partial inefficiency of antibiotics in the treatment of periodontal disease is a key factor limiting the growth of the periodontal therapeutics market. The use of antibiotics in the treatment of gum disease is limited, especially in the later stages of severe periodontitis owing to the low efficiency of treating bacterial infection and healing pockets.

Antibiotic treatment is mostly used in combination with oral surgery or dental cleaning procedures. Furthermore, the overuse and misuse of antibiotics in disease treatment may result in antimicrobial resistance. These factors are expected to hamper the periodontal therapeutics market growth over the forecast period.

COVID-19 Impact Analysis

The global periodontal therapeutics market has experienced a downturn due to the outbreak of COVID-19. In the first half of 2020, there was a slight decrease in the sales growth of antibiotics used for the treatment of periodontal disease. This can be attributed to a reduction in hospital visits for dental services and a decrease in prescriptions from dentists around the world.

Russia Ukraine Conflict Analysis

The global periodontal therapeutic market may be indirectly affected by the ongoing conflict between Russia and Ukraine. Economic sanctions imposed on Russia by several countries due to the conflict have led to repercussions in the Russian economy. As a result, the dental healthcare industry, including the periodontal therapeutic market, may be impacted.

The supply of dental equipment from Russia to other countries may be disrupted due to the war, as Russia both imports and exports dental equipment. Additionally, major pharmaceutical companies such as Pfizer, Bayer, and Sanofi have deferred new investments or developments in Russia, which has led to disruptions in the medicine supply chain. These disruptions caused by the conflict have had a negative impact on the global periodontal therapeutics market.

For more details on this report - Request For Sample

Segment Analysis

The global periodontal therapeutics market is segmented based on treatment, disease type, distribution channel, and region.

Gingivitis segment to hold the highest global periodontal therapeutics market share

The gingivitis segment is expected to dominate and account for 54.7% of the global periodontal therapeutics market share over the forecast period. Gingivitis is one of the most common types of periodontitis. This is usually caused by poor oral hygiene and red, swollen gums. They also tend to bleed easily.

The treatment of gingivitis focuses on reducing inflammation, removing plaque, and establishing good oral hygiene habits to prevent plaque build-up. Mouthwash, topical antibiotics, or antiseptics may be recommended. For more serious infections or periodontitis, the dentist may recommend oral antibiotics. For instance, over-the-counter medicated toothpaste, mouth rinses, and mouth sprays are very safe, provided they are used as directed. Therefore, this segment growth will boost the global periodontal therapeutics market growth over the forecast period.

Geographical Analysis

The presence of major players to dominate the North America region.

North America is expected to have a dominant global periodontal therapeutics market share of around 1/3rd of this market. The U.S. is the largest revenue contributor in North America, and the presence of a large dental workforce in this region indicates its dominance in the global market. For instance, according to the American Dental Association, as of 2022, there are 202,536 professionally active dentists in the U.S. There are 60.8 dentists per 100,000 U.S. population.

Competitive Landscape

The major global players in the market include Kaken Pharmaceutical Co. Ltd., Bausch Health, Colgate-Palmolive, Medicom, Pfizer Inc., 3M, Den-Mat Holdings, LLC, Dentsply Sirona, Xttrium Laboratories, Inc., and Dexcel Pharma.

Why Purchase the Report?

  • To visualize the global periodontal therapeutics- market segmentation based on treatment, disease type, distribution channel, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global periodontal therapeutics market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global periodontal therapeutics market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Treatment
  • 3.2. Snippet by Disease Type
  • 3.3. Snippet by Distribution Channel
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The increasing demand for better oral hygiene to drive global periodontal therapeutics market growth during the forecast period
    • 4.1.2. Restraints
      • 4.1.2.1. The clinical inefficiencies of antibiotics to hamper periodontal therapeutics market growth
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. Present COVID-19 Scenario
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Treatment

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 7.1.2. Market Attractiveness Index, By Treatment
  • 7.2. Systemic Antibiotics
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Local Antibiotics

8. By Disease Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 8.1.2. Market Attractiveness Index, By Disease Type
  • 8.2. Gingivitis*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Chronic Periodontitis
  • 8.4. Aggressive Periodontitis
  • 8.5. Necrotizing Periodontal Disease
  • 8.6. Others

9. By Distribution Channel

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.1.2. Market Attractiveness Index, By Distribution Channel
  • 9.2. Retail Pharmacies and Drug Stores*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Hospital Pharmacies
  • 9.4. Dental Clinics
  • 9.5. E-Commerce

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Kaken Pharmaceutical Co. Ltd.*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Bausch Health
  • 12.3. Colgate-Palmolive
  • 12.4. Medicom
  • 12.5. Pfizer Inc.
  • 12.6. 3M
  • 12.7. Den-Mat Holdings, LLC
  • 12.8. Dentsply Sirona
  • 12.9. Xttrium Laboratories, Inc.
  • 12.10. Dexcel Pharma

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제